186 related articles for article (PubMed ID: 17414513)
1. Prostate cancer prevention.
Nelson WG
Curr Opin Urol; 2007 May; 17(3):157-67. PubMed ID: 17414513
[TBL] [Abstract][Full Text] [Related]
2. The role of inflammation and infection in the pathogenesis of prostate carcinoma.
Wagenlehner FM; Elkahwaji JE; Algaba F; Bjerklund-Johansen T; Naber KG; Hartung R; Weidner W
BJU Int; 2007 Oct; 100(4):733-7. PubMed ID: 17662075
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and prostate cancer.
Sugar LM
Can J Urol; 2006 Feb; 13 Suppl 1():46-7. PubMed ID: 16526982
[TBL] [Abstract][Full Text] [Related]
4. Prostate carcinogenesis and inflammation: emerging insights.
Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG
Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
Hofer MD; Kuefer R; Maier C; Herkommer K; Perner S; Demichelis F; Paiss T; Vogel W; Rubin MA; Hoegel J
Cancer Res; 2009 Jan; 69(2):640-6. PubMed ID: 19147579
[TBL] [Abstract][Full Text] [Related]
6. ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
Tomlins SA; Bjartell A; Chinnaiyan AM; Jenster G; Nam RK; Rubin MA; Schalken JA
Eur Urol; 2009 Aug; 56(2):275-86. PubMed ID: 19409690
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
8. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
9. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
10. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
Rittmaster RS
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability in inflammation pathways and prostate cancer risk.
Sun J; Turner A; Xu J; Grönberg H; Isaacs W
Urol Oncol; 2007; 25(3):250-9. PubMed ID: 17483024
[TBL] [Abstract][Full Text] [Related]
12. Inflammation, atrophy, and prostate carcinogenesis.
De Marzo AM; Nakai Y; Nelson WG
Urol Oncol; 2007; 25(5):398-400. PubMed ID: 17826659
[TBL] [Abstract][Full Text] [Related]
13. Prostate inflammation and its potential impact on prostate cancer: a current review.
Haverkamp J; Charbonneau B; Ratliff TL
J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
[TBL] [Abstract][Full Text] [Related]
14. Dietary influences on endocrine-inflammatory interactions in prostate cancer development.
Ho E; Boileau TW; Bray TM
Arch Biochem Biophys; 2004 Aug; 428(1):109-17. PubMed ID: 15234275
[TBL] [Abstract][Full Text] [Related]
15. Genetic and microenvironmental implications in prostate cancer progression and metastasis.
Alberti C
Eur Rev Med Pharmacol Sci; 2008; 12(3):167-75. PubMed ID: 18700688
[TBL] [Abstract][Full Text] [Related]
16. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms in the biology of prostate cancer.
Schulz WA; Hoffmann MJ
Semin Cancer Biol; 2009 Jun; 19(3):172-80. PubMed ID: 19429481
[TBL] [Abstract][Full Text] [Related]
18. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
[TBL] [Abstract][Full Text] [Related]
19. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer prevention: past, present, and future.
Fleshner N; Zlotta AR
Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
